Cancer statistics, 2012

Cited by (1,032)

Items 601–700 of 1,032

1. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer
   David A. Johnson, Alan N. Barkun, Larry B. Cohen, Jason A. Dominitz, Tonya R. Kaltenbach, Myriam Martel, Douglas J. Robertson, Clement Richard Boland, Frances M. Giardello, David A. Lieberman et al. · 2014 · Gastrointestinal Endoscopy
2. Utilizing time‐driven activity‐based costing to understand the short‐ and long‐term costs of treating localized, low‐risk prostate cancer
   Aaron A. Laviana, Annette M. Ilg, Darlene Veruttipong, Hung‐Jui Tan, Michael A. Burke, Douglas R. Niedzwiecki, Patrick A. Kupelian, Chris R. King, Michael L. Steinberg, Chandan R. Kundavaram et al. · 2015 · Cancer
3. U.S. Food and Drug Administration Approval Summary: Erlotinib for the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 19 Deletions or Exon 21 (L858R) Substitution Mutations
   Sean Khozin, Gideon Michael Blumenthal, Xiaoping Jiang, Kun He, Karen K. Boyd, Anthony J. Murgo, Robert L. Justice, Patricia Keegan, Richard Pazdur · 2014 · The Oncologist
4. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer
   Yoshinaga Okugawa, Yuji Toiyama, Shusuke Toden, Hiroki Mitoma, Takeshi Nagasaka, Koji Tanaka, Yasuhiro Inoue, Masato Kusunoki, Clement Richard Boland, Ajay Goel · 2015 · Gut
5. SREBP-1 is an independent prognostic marker and promotes invasion and migration in breast cancer
   Jisheng Bao, Liping Zhu, Qi Zhu, Jianhua Su, Menglan Liu, Wei Huang · 2016 · Oncology Letters
6. Neonatal Fc Receptor Expression in Dendritic Cells Mediates Protective Immunity against Colorectal Cancer
   Kristi Baker, Timo Räth, Magdalena B. Flak, Janelle C. Arthur, Zhangguo Chen, Jonathan N. Glickman, Inti Zlobec, Eva Karamitopoulou, Matthew D. Stachler, Robert Daniel Odze et al. · 2013 · Immunity
7. The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer
   John K. Chan, Kevin Blansit, Tuyen K. Kiet, Alexander E. Sherman, Gabriel Wong, Christine A. Earle, Lilly Bourguignon · 2014 · Gynecologic Oncology
8. Targeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatment
   Haiying Cheng, Marina Shcherba, Gopichand Pendurti, Yuanxin Liang, Bilal Piperdi, Roman Perez-Soler · 2014 · Lung Cancer Management
9. Sensitivity of endoscopic retrograde cholangiopancreatography standard cytology: 10-y review of the literature
   Atuhani S. Burnett, Thomas J. Calvert, Ravi J. Chokshi · 2013 · Journal of Surgical Research
10. Cell-Based Drug Combination Screening with a Microfluidic Droplet Array System
    Guan-Sheng Du, Jian‐Zhang Pan, Shi-Ping Zhao, Ying Zhu, Jaap M. J. den Toonder, Qun Fang · 2013 · Analytical Chemistry
11. Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells
    Hiroshi Hirata, Yuji Hinoda, Varahram Shahryari, G Deng, Yuichiro Tanaka, Z. Laura Tabatabai, Ravinder Dahiya · 2014 · British Journal of Cancer
12. FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity
    Krishna Soujanya Gunturu, Xiaopan Yao, Xiangyu Cong, Jaykumar Ranchodbhai Thumar, Howard S. Höchster, Stacey Stein, Jill Lacy · 2012 · Medical Oncology
13. Fully automatic segmentation of breast ultrasound images based on breast characteristics in space and frequency domains
    Min Xian, Yingtao Zhang, Heng-Da Cheng · 2014 · Pattern Recognition
14. Mechanisms involved in breast cancer liver metastasis
    Rui Ma, Yi-Li Feng, Shuang Lin, Jiang Chen, Hui Min Lin, Xiao Liang, Heming Zheng, Xiujun Cai · 2015 · Journal of Translational Medicine
15. BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study
    Jamie Lee Lesnock, Kathleen M. Darcy, Chunqiao Tian, Julie A. DeLoia, Melissa M. Thrall, Chris M. Zahn, Deborah Kay Armstrong, Michael J. Birrer, Thomas C. Krivak · 2013 · British Journal of Cancer
16. Detection of miR-34a Promoter Methylation in Combination with Elevated Expression of c-Met and β-Catenin Predicts Distant Metastasis of Colon Cancer
    Helge Siemens, Jens H. L. Neumann, René Jackstadt, Ulrich Mansmann, David A. Horst, Thomas Kirchner, Heiko Hermeking · 2012 · Clinical Cancer Research
17. Expression and Prognostic Significance of lncRNA MALAT1 in Pancreatic Cancer Tissues
    Jianghua Liu, Gang Chen, Yi‐Wu Dang, Chunjun Li, Dianzhong Luo · 2014 · Asian Pacific Journal of Cancer Prevention
18. MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1
    Tae‐Su Han, Keun Hur, Guorong Xu, Boram Choi, Yoshinaga Okugawa, Yuji Toiyama, Hiroko Oshima, Masanobu Oshima, Hyuk-Joon Lee, V. Narry Kim et al. · 2014 · Gut
19. Biological and pathological activities of interleukin-22
    Mirna Perusina Lanfranca, Yanwei Lin, Jing‐Yuan Fang, Weiping Zou, Timothy L. Frankel · 2016 · Journal of Molecular Medicine
20. Preparation of carbon quantum dots- quinic acid for drug delivery of gemcitabine to breast cancer cells
    Shabnam Samimi, Mehdi Shafiee Ardestani, Farid Abedin Dorkoosh · 2020 · Journal of Drug Delivery Science and Technology
21. Metabolomic signatures of aggressive prostate cancer
    Jonathan E. McDunn, Zhen Li, Klaus‐Peter Adam, Bruce P Neri, Robert L. Wolfert, Michael V. Milburn, Yair Lotan, Thomas M. Wheeler · 2013 · The Prostate
22. Clinicopathological and prognostic significance of programmed cell death ligand1 (PD-L1) expression in patients with non-small cell lung cancer: a meta-analysis.
    Zhenkui Pan, Feng Ye, Xuan Wu, Han‐Xiang An, Jingxun Wu · 2015 · PubMed Central
23. PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients
    Tao Han, Daimin Xiang, Wen Ce Sun, Na Liu, Huanlin Sun, Wen Wen, Wei-Feng Shen, Ruoyu Wang, Cheng Yeh Chen, Xue Bing Wang et al. · 2015 · Journal of Hepatology
24. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes
    Jingcheng Yang, Jinyuan Lin, Tianxiao Liu, Ting Chen, Shang‐Ling Pan, Weiqiang Huang, Shikang Li · 2014 · Lung Cancer
25. Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction
    Sabrina Danilin, Alyssa R. Merkel, Joshua Johnson, Rachelle W. Johnson, James Edwards, Julie A. Rhoades Sterling · 2012 · OncoImmunology
26. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes
    Xu Ma, Jia Zhou, Cheng-Xiang Zhang, Xiuying Li, Nan Li, Rui-Jun Ju, Ji‐Feng Shi, Mengge Sun, Weiyu Zhao, Li-Min Mu et al. · 2013 · Biomaterials
27. A Novel 111In-Labeled Anti–Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer
    Kristell L.S. Chatalic, Joke Veldhoven-Zweistra, Michiel Bolkestein, Sander A.H. Hoeben, Gerben A. Koning, Otto C. Boerman, Marion de Jong, Wytske M. van Weerden · 2015 · Journal of Nuclear Medicine
28. Hashimoto’s Thyroiditis as a Risk Factor of Papillary Thyroid Cancer May Improve Cancer Prognosis
    Yu Lun, Xiaoyu Wu, Qian Xia, Yanshuo Han, Xiaoyu Zhang, Zhimin Liu, Fengyi Wang, Zhiquan Duan, Shijie Xin, Jian Zhang · 2013 · Otolaryngology
29. Pathways to Breast Cancer Recurrence
    Aamir Ahmad · 2013 · ISRN Oncology
30. Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer
    Raymond Uyiosa Osarogiagbon, Obiageli Uchenna Ogbata, Xinhua Yu · 2013 · The Annals of Thoracic Surgery
31. PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer
    Bai Xiang, Da‐Wen Dong, Nianqiu Shi, Wei Gao, Zhenzhen Yang, Yi Cui, Cao De-ying, Xian Qi · 2013 · Biomaterials
32. Phase Ib Study of Panobinostat and Bortezomib in Relapsed or Relapsed and Refractory Multiple Myeloma
    Jesús F. San Miguel, Paul Gerard Guy Richardson, Andreas Günther, Orhan Sezer, David Samuel DiCapua Siegel, Joan Bladé, Richard LeBlanc, Heather J. Sutherland, Monika Sopala, Kaushal Mishra et al. · 2013 · Journal of Clinical Oncology
33. Evolution of cellular morpho-phenotypes in cancer metastasis.
    Wu, Pei-Hsun, Phillip, Jude M., Khatau, Shyam B., Chen, Wei-Chiang, Stirman, Jeffrey, Rosseel, Sophie, Tschudi, Katherine, Van Patten, Joshua, Wong, Michael, Gupta, Sonal et al. · 2015 · Scientific Reports
34. Regorafenib (BAY 73‐4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer
    Roberta Schmieder, Jens Hoffmann, Michael Becker, Ajay Bhargava, Tina Müller, Nicole Kahmann, Peter Ellinghaus, Robert A Adams, André Rosenthal, Karl‐Heinz Thierauch et al. · 2013 · International Journal of Cancer
35. 25 Years of Small Molecular Weight Kinase Inhibitors: Potentials and Limitations
    Doriano Fabbro · 2014 · Molecular Pharmacology
36. Postoperative Complications in Patients With Rectal Cancer Are Associated With Delays in Chemotherapy That Lead to Worse Disease-free and Overall Survival
    Sarah E. Tevis, Brittney M. Kohlnhofer, Sarah Stringfield, Eugene F. Foley, Bruce A. Harms, Charles P. Heise, Gregory D. Kennedy · 2013 · Diseases of the Colon & Rectum
37. Terpenoids from Zingiber officinale (Ginger) Induce Apoptosis in Endometrial Cancer Cells through the Activation of p53
    Yang Liu, Rebecca J. Whelan, Bikash Ranjan Pattnaik, Kai D. Ludwig, Enketeswara Subudhi, Helen Rowland, Nick Claussen, Noah A. Zucker, Shitanshu Uppal, David M. Kushner et al. · 2012 · PLoS ONE
38. The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells
    Michele Cioffi, Sara Maria David Trabulo, Yolanda Sanchez-Ripoll, Irene Miranda‐Lorenzo, Enza Lonardo, Jorge Dorado, Catarina Reis Vieira, Juan Carlos Ramírez, Manuel M. Hidalgo, Alexandra Aicher et al. · 2015 · Gut
39. Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures
    Dharanija Madhavan, Katarina Ćuk, Barbara Burwinkel, Rongxi Yang · 2013 · Frontiers in Genetics
40. Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion
    Ethan Basch, Thomas K. Oliver, Andrew Julian Vickers, Ian Murchie Thompson, Philip W. Kantoff, Howard L. Parnes, D. Andrew Loblaw, Bruce J. Roth, James Koudy Williams, Robert K. Nam · 2012 · Journal of Clinical Oncology
41. The Impact of Repeat Biopsies on Infectious Complications in Men with Prostate Cancer on Active Surveillance
    Behfar Ehdaie, Emily Vertosick, Massimiliano Spaliviero, Anna Giallo-Uvino, Ying Taur, Maryellen O’Sullivan, Jennifer Livingston, Pramod C. Sogani, James Andrew Eastham, Peter T. Scardino et al. · 2013 · The Journal of Urology
42. Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment
    Luc J. Martin · 2015 · Marine Drugs
43. Hypoxia Induced Aggressiveness of Prostate Cancer Cells Is Linked with Deregulated Expression of VEGF, IL-6 and miRNAs That Are Attenuated by CDF
    Bin Bao, Aamir Ahmad, Dejuan Kong, Shadan S. Ali, Asfar Sohail Azmi, Yiwei Li, Sanjeev Banerjee, Subhash Padhyé, Fazlul H. Sarkar · 2012 · PLoS ONE
44. Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay
    Robert E. Bristow, Alan Smith, Zhen Zhang, Daniel W. Chan, Gillian Crutcher, Eric T. Fung, Donald Gordon Munroe · 2012 · Gynecologic Oncology
45. Exposure to Bisphenol A Correlates with Early-Onset Prostate Cancer and Promotes Centrosome Amplification and Anchorage-Independent Growth In Vitro
    Pheruza Tarapore, Jun Ying, Bin Ouyang, Barbara Morales Burke, Bruce R. Bracken, Shuk‐Mei Ho · 2014 · PLoS ONE
46. A role for p38 MAPK in head and neck cancer cell growth and tumor‐induced angiogenesis and lymphangiogenesis
    Kantima Leelahavanichkul, Panomwat Amornphimoltham, Alfredo Molinolo, John R. Basile, Sittichai Koontongkaew, Jorge Silvio Gutkind · 2013 · Molecular Oncology
47. Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion/metastasis in serous ovarian cancer
    Junjun Qiu, Yingying Lin, Jingxin Ding, Weiwei Feng, Hongyan Jin, Keqin Hua · 2015 · International Journal of Oncology
48. Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer
    Mitsuro Kanda, Akira Mizuno, Chie Tanaka, Daisuke Kobayashi, Michitaka Fujiwara, Naoki Iwata, Masamichi Hayashi, Suguru Yamada, Goro Nakayama, Tsutomu Fujii et al. · 2016 · Medicine
49. miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1
    Yi-Ying Wu, Yuh‐Ling Chen, Yun-Chia Jao, I‐Shan Hsieh, Kung‐Chao Chang, Tse-Ming Hong · 2013 · Angiogenesis
50. Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients
    Ignazio Tarantino, René Warschkow, Mathias Worni, Thomas Cerny, Alexis B. Ulrich, Bruno Martin Schmied, Ulrich Güller · 2014 · Annals of Surgery
51. Metastatic Renal Cell Carcinoma: Radiologic Findings and Assessment of Response to Targeted Antiangiogenic Therapy by Using Multidetector CT
    Blanca Paño, Carmen Sebastià, Laura Buñesch Villalba, Rafael Salvador Izquierdo, Amy Berrington de González, Carlos Nicolau Molina · 2013 · Radiographics
52. Molecular Homology and Difference between Spontaneous Canine Mammary Cancer and Human Breast Cancer
    Deli Liu, Huan Xiong, Angela E. Ellis, Nicole C. Northrup, Carlos O. Rodriguez, Ruth M O'Regan, Stephen Dalton, Shaying Zhao · 2014 · Cancer Research
53. Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high‐grade lesions
    Valentina Corino, Eros Montin, A. Messina, Paolo Giovanni Casali, Alessandro Gronchi, Alfonso Vittorio Marchianò, Luca Tommaso Mainardi · 2017 · Journal of Magnetic Resonance Imaging
54. Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review
    Ernesto Sosa, Gail C. D’Souza-Rushton, Aamna Akhtar, Melissa Sur, Kyra Love, Jeanette Duffels, Dan J. Raz, Jae Yul Kim, Virginia Chih-Yi Sun, Loretta Erhunmwunsee · 2021 · CA A Cancer Journal for Clinicians
55. Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers
    Zhen Dong Huang, Yang Yang, Yucui Jiang, Juan Shao, Xulun Sun, Jiangning Chen, Lei Dong, Junfeng Zhang · 2012 · Biomaterials
56. Magnetic graphene-based nanotheranostic agent for dual-modality mapping guided photothermal therapy in regional lymph nodal metastasis of pancreatic cancer
    Sheng Wang, Qin Zhang, Xian Fu Luo, Ji Li, Hang He, Feng Yang, Di Yang, Chen Jin, Xin Jiang, Shun Shen et al. · 2014 · Biomaterials
57. An Updated Report of the Trends in Cancer Incidence and Mortality in Japan
    Kota Katanoda, Tomohiro Matsuda, Ayako Matsuda, Akiko Shibata, Yoshikazu Nishino, Manabu Fujita, Midori Soda, Akiko Ioka, Tomotaka Sobue, Hiroshi Nishimoto · 2013 · Japanese Journal of Clinical Oncology
58. Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer
    Emily K. Mader, Greg W. Butler, Sean Christopher Dowdy, Andrea Mariani, Keith L. Knutson, Mark J. Federspiel, Stephen J. Russell, Evanthia Galanis, Allan B. Dietz, Kah-Whye Peng · 2013 · Journal of Translational Medicine
59. Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis
    Akimasa Takahashi, Fuminori Kimura, Akiyoshi Yamanaka, Akie Takebayashi, Nobuyuki Kita, Kentaro Takahashi, Takashi Murakami · 2014 · Cancer Cell International
60. Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation
    Comron Hassanzadeh, Soumon F. Rudra, A. Bommireddy, William G. Hawkins, Andrea Wang‐Gillam, Ryan Courtney Fields, Bin Cai, Justin Park, Olga Green, Michael Charles Roach et al. · 2020 · Advances in Radiation Oncology
61. New insights into human papillomavirus-associated head and neck squamous cell carcinoma.
    Paolo Boscolo‐Rizzo, Annarosa Del Mistro, Francesco Bussu, Valentina Lupato, Lorena Baboçi, Giovanni Almadori, Maria Cristina Da Mosto, Gaetano Paludetti · 2013 · PubMed Central
62. Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer
    Ganepola A.P. Ganepola · 2014 · World Journal of Gastrointestinal Oncology
63. Pathological Examination of Radical Prostatectomy Specimens in Men with Very Low Risk Disease at Biopsy Reveals Distinct Zonal Distribution of Cancer in Black American Men
    Debasish Sundi, Oleksandr N. Kryvenko, H. Ballentine Carter, Ashley Evan Ross, Jonathan I. Epstein, Edward Matthew Schaeffer · 2013 · The Journal of Urology
64. miR-141 and miR-200c as Markers of Overall Survival in Early Stage Non-Small Cell Lung Cancer Adenocarcinoma
    Rut Tejero, Alfons Navarro, Marc Campayo, Núria Viñolas, Ramón María Marrades, Anna Cordeiro, Marc Ruíz-Martínez, Sandra Santasusagna, Laureano Molins, José Ramírez et al. · 2014 · PLoS ONE
65. Adaptation or selection—mechanisms of castration-resistant prostate cancer
    Yang Zong, Andrew S. Goldstein · 2012 · Nature Reviews Urology
66. Incidence and survival patterns of cutaneous T-cell lymphomas in the United States
    Muhammad Imam, Pareen J. Shenoy, Christopher R. Flowers, Adrienne Alise Phillips, Mary Jo Lechowicz · 2012 · Leukemia & lymphoma/Leukemia and lymphoma
67. Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood–Brain Barrier
    Ilaria Monaco, Simona Camorani, David Colecchia, Erica Locatelli, Pierpaolo Calandro, Anaïs Oudin, Simone P. Niclou, Claudio Arra, Mario Chiariello, Laura Cerchia et al. · 2017 · Journal of Medicinal Chemistry
68. Impact of Smoking and Smoking Cessation on Oncologic Outcomes in Primary Non–muscle-invasive Bladder Cancer
    Michael Rink, Helena F. Furberg, Emily Craig Zabor, Evanguelos N. Xylinas, Marko M. Babjuk, Armin Pycha, Yair Lotan, Pierre I. Karakiewicz, Giacomo Novara, Brian D. Robinson et al. · 2012 · European Urology
69. Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma
    Naotake Funamizu, Chaoxin Hu, Curtis Lacy, Aaron J. Schetter, Geng Zhang, Peijun He, Jochen Gaedcke, Michael B. Ghadimi, Β. Michael Ghadimi, Harris G. Yfantis et al. · 2012 · International Journal of Cancer
70. KRAS Mutations as Prognostic and Predictive Markers in Non–Small Cell Lung Cancer
    Petra Martin, Natasha B. Leighl, Ming‐Sound Tsao, Frances A. Shepherd · 2013 · Journal of Thoracic Oncology
71. Multi-Field-of-View Framework for Distinguishing Tumor Grade in ER+ Breast Cancer From Entire Histopathology Slides
    Ajay N. Basavanhally, Shridar Ganesan, Michael D. Feldman, Natalie N. C. Shih, Carolyn Mies, John Tomaszewski, Anant Madabhushi · 2013 · IEEE Transactions on Biomedical Engineering
72. Preoperative Plasma Hyperfibrinogenemia is Predictive of Poor Prognosis in Patients with Nonmetastatic Colon Cancer
    Hae‐Jung Son, Ji Won Park, Hee Jin Chang, Dae Yong Kim, Byung Chang Kim, Sun Young Kim, Sung Chan Park, Hyo Seong Choi, Jae Hwan Oh · 2013 · Annals of Surgical Oncology
73. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer
    Hyun Kyung Lim, Jung Hwan Baek, Jeong Hyun Lee, Won Bae Kim, Tae Yong Kim, Young Kee Shong, Suck Joon Hong · 2014 · European Radiology
74. Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer
    Nikos G. Gavalas, Michalis Liontos, Sofia Paraskevi Trachana, Tina Bagratuni, Calliope Arapinis, Christine‐Ivy Liacos, Meletios Athanasios Dimopoulos, Aristotle Bamias · 2013 · International Journal of Molecular Sciences
75. Pediatric T‐cell acute lymphoblastic leukemia
    Kristina Karrman, Bertil Johansson · 2016 · Genes Chromosomes and Cancer
76. Targeted and pH‐Responsive Delivery of Doxorubicin to Cancer Cells Using Multifunctional Dendrimer‐Modified Multi‐Walled Carbon Nanotubes
    Shihui Wen, Hui Liu, Hongdong Cai, Mingwu Shen, Xiangyang Shi · 2013 · Advanced Healthcare Materials
77. Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine
    Bryan M. Wittmann, Steven M. Stirdivant, Matthew W. Mitchell, Jacob E. Wulff, Jonathan E. McDunn, Zhen Li, Aphrihl Dennis-Barrie, Bruce P Neri, Michael V. Milburn, Yair Lotan et al. · 2014 · PLoS ONE
78. Pancreatitis-Diabetes-Pancreatic Cancer
    Dana K. Andersen, Åke Andrén‐Sandberg, Eric J. Duell, Michael Goggins, Murray Korc, Gloria M. Petersen, Jill Palmer Smith, David Clement Whitcomb · 2013 · Pancreas
79. A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma
    Cheng Wang, Jicheng Hu, Meiling Lü, Hongwei Gu, Xiaojun Zhou, Xi Chen, Ke Zen, Chen‐Yu Zhang, Tiehui Zhang, Jingping Ge et al. · 2015 · Scientific Reports
80. Colonoscopy utilization and outcomes 2000 to 2011
    David A. Lieberman, J. Lucas Williams, Jennifer L. Holub, Cynthia D. Morris, Judith R. Logan, Glenn M. Eisen, Patricia A. Carney · 2014 · Gastrointestinal Endoscopy
81. Nuclear Factor of Activated T-cell Activity Is Associated with Metastatic Capacity in Colon Cancer
    Manish Kumar Tripathi, Natasha G. Deane, Jing Zhu, Hanbing An, Shinji Mima, Xiaojing Wang, Sekhar Padmanabhan, Zhiao Shi, Naresh Prodduturi, Kristen Keon Ciombor et al. · 2014 · Cancer Research
82. Uterine papillary serous cancer: A review of the literature
    Marcela G.del Carmen, Michael J. Birrer, John O. Schorge · 2012 · Gynecologic Oncology
83. Selective Tropism of Seneca Valley Virus for Variant Subtype Small Cell Lung Cancer
    John Thomas Poirier, Irina Dobromilskaya, Whei F. Moriarty, Craig D. Peacock, Christine L. Hann, Charles M. Rudin · 2013 · JNCI Journal of the National Cancer Institute
84. Mesenchymal gene program–expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance
    Rachel A. Davidowitz, Laura M. Selfors, Marcin Iwanicki, Kevin Meyer Elias, Alison M. Karst, Huiying Piao, Tan A. Ince, Michael G. Drage, Judy Dering, Gottfried E. Konecny et al. · 2014 · Journal of Clinical Investigation
85. Effect of Postoperative Complications on Adjuvant Chemotherapy Use for Stage III Colon Cancer
    Ryan P. Merkow, David J. Bentrem, Mary F. Mulcahy, Jeanette W. Chung, Daniel Erik Abbott, Thomas E. Kmiecik, Andrew K. Stewart, David Porter Winchester, Clifford Y. Ko, Karl Y. Bilimoria · 2013 · Annals of Surgery
86. Pharmacokinetics of pterostilbene in S prague‐ D awley rats: The impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability
    Samuel Chao Ming Yeo, Paul C. Ho, Hai‐Shu Lin · 2013 · Molecular Nutrition & Food Research
87. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression
    Yang Li, Zhongxin Zhao, Chuanhui Xu, Zhuqing Zhou, Zhe Zhu, Tiangeng You · 2014 · Cancer Letters
88. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer
    Syed Shahidul Islam, Reza Bayat Mokhtari, Abu Shadat Mohammod Noman, Mohammed J. Uddin, M Z Rahman, Mohammad Ali Azadi, Alexandre R. Zlotta, Theodorus van der Kwast, Herman Yeger, Walid A. Farhat · 2015 · Molecular Carcinogenesis
89. Diagnosis and Management of Neurolymphomatosis
    Joachim M. Baehring, Tracy T. Batchelor · 2012 · The Cancer Journal
90. Impact of Smoking on Oncologic Outcomes of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy
    Michael Rink, Evanguelos N. Xylinas, Vitaly Margulis, Eugene K. Cha, Behfar Ehdaie, Jay D. Raman, Felix K.‐H. Chun, Kazumasa Matsumoto, Yair Lotan, Helena F. Furberg et al. · 2012 · European Urology
91. The Physical Consequences of Gynecologic Cancer Surgery and Their Impact on Sexual, Emotional, and Quality of Life Issues
    Jeanne Carter, Cara Stabile, Abigail Gunn, Yukio Sonoda · 2013 · The Journal of Sexual Medicine
92. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway
    Wei Xu, Ziwei Wang, Wei Zhang, Kun Qian, Hui Li, Dequan Kong, Yuqiang Li, Yu-Cheng Tang · 2014 · Cancer Letters
93. Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers? A prospective study
    Gennaro Galizia, Eva Lieto, Ferdinando De Vita, Francesca Ferraraccio, Anna Ginevra Immacolata Zamboli, Andrea Mabilia, ANNAMARIA AURICCHIO, Paolo Castellano, Vincenzo Napolitano, Michele Orditura · 2013 · International Journal of Colorectal Disease
94. Development and application of a new electronic nose instrument for the detection of colorectal cancer
    Eric W. Westenbrink, Ramesh Pulendran Arasaradnam, N. O'Connell, C. Bailey, Chuka U Nwokolo, K.D. Bardhan, James Anthony Covington · 2014 · Biosensors and Bioelectronics
95. Phase 2 Trial of Single-agent Everolimus in Chemotherapy-naive Patients with Castration-resistant Prostate Cancer (SAKK 08/08)
    Arnoud J. Templeton, Valérie Dutoit, Richard L. Cathomas, Christian Alexander Rothermundt, Daniela Bärtschi, C. Droege, Oliver Pascal Gautschi, Markus Borner, Eva Fechter, Frank Stenner et al. · 2013 · European Urology
96. Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors
    David N. Danforth · 2013 · Breast Cancer Research
97. Olfactory System of Highly Trained Dogs Detects Prostate Cancer in Urine Samples
    Gianluigi Taverna, Lorenzo Tidu, Fabio Grizzi, Valter Torri, Alberto Mandressi, Paolo Sardella, Giuseppe La Torre, Giampiero Cocciolone, Mauro Seveso, Guido Giusti et al. · 2014 · The Journal of Urology
98. Graphene Oxide–Silver Nanocomposite Enhances Cytotoxic and Apoptotic Potential of Salinomycin in Human Ovarian Cancer Stem Cells (OvCSCs): A Novel Approach for Cancer Therapy
    Yun‐Jung Choi, Sangiliyandi Gurunathan, Jin‐Hoi Kim · 2018 · International Journal of Molecular Sciences
99. Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer
    Laura Chambers, Emily Esakov Rhoades, Rashmi Bharti, Chad Braley, Surabhi Tewari, Lexie Trestan, Zahraa Alali, Defne Bayık, Justin Durla Lathia, Naseer Sangwan et al. · 2022 · Cancer Research
100. Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer
     Miranda Fong, Shunying Jin, Madhavi J. Rane, Raj K. Singh, Ramesh C. Gupta, Sham S. Kakar · 2012 · PLoS ONE